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The effect of ethanol, glycerol, propylene glycol, polysorbate-80 and sodium lauryl sulfate on the 
aqueous solubility of sparfloxacin was studied. It was found that all these substances increase the 
aqueous solubility of the drug.  Of the solubilizing agents used, sodium lauryl sulfate was observed to be 
the most effective.  The increase was in the following order: sodium lauryl sulfate > polysorbate-80 > 





Alteration of solute or solvent is the major approach 
for increasing aqueous drug solubility.  Solvent 
alteration is the most effective means of producing 
a thermodynamically stable increase in solubility 
(Yalkowsky, 1999).  Sparfloxacin,5-Amino-1-
cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-
difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic 
acid is a difluoroquinolone antibacterial agent 
belonging to the third generation quinolones, 
Clinically, it is very effective in the treatment of 
streptococci infections.  Its mechanism of action 
involves the inhibition of DNA synthesis by 
promoting cleavage of bacterial DNA in the DNA-
enzyme complexes of DNA gyrase and type iv 
topoisomerase, resulting in rapid bacterial death 
(Hooper 1999). The water solubility is very limited. 
With such low aqueous solubility, the purpose of the 
study was to investigate how cosolvents and 
surfactants might enhance the drug’s aqueous 
solubility.  Numerous studies (Zhao et al 1999; 
Alkhamis et al 2003; Mbah 2006) have reported the 
effect of cosolvency and micellization on the 
solubility of slightly soluble drugs. Reports have 
also shown that these techniques have resulted in 
the formulation of drugs with limited water solubility 
into various liquid and parenteral dosage forms 
(Varia et al 1991; Powell et al 1998; Khalil et al 
2000). It is against this background, that the present 
study explores the enhancement of aqueous 
solubility of sparfloxacin by ethanol, glycerol, 
propylene glycol, polysorbate-80 and sodium lauryl 
sulfate while envisaging the potentials of being 
formulated into pharmaceutical liquid dosage forms. 
 
Materials and Methods 
 
Materials and apparatus: Sparfloxacin 
(International PVT Ltd, India), and all other solvents 
were of analytical grade (BDH). Ultraviolet/Visible 
spectrophotometer (UV 2102 PC Unico) was used 
to measure the absorbance readings. 
 
Standard solution: The stock solution of 
sparfloxacin (20 µg/ml) was prepared in methanol.  
Aliquots (2- 10 µg/ml) of the standard stock solution 
were pipetted into a 10 ml volumetric flask and 
diluted to volume with methanol. 
 
Solubility determination: The solubility was 
determined by placing excess of sparfloxacin (200 
mg) in flasks containing 10 ml of water, cosolvent 
and surfactant solutions respectively.  The flasks 
were stoppered and shaken at 25 º C for 24 h.  
After equilibration, the supernatant was filtered and 
the absorbance taken after dilution at a maximum 
wavelength of 305 nm.  The sparfloxacin 
concentration was calculated from the calibration 
graph. 
 
Results and Discussion 
 
The calibration curve of sparfloxacin was linear in 
the concentration range of 2 – 10 µg/ml.  
Absorbance versus concentration relationship is 
described by regression equation:  A = 
0.0534C+0.0129 (r =0.9982).  The effect of ethanol, 
glycerol and propylene glycol on the aqueous 
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the cosolvent. The upper graph (▲---▲ ) is the ethanol-water system; middle graph 
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Table 1:  Effect of cosolvents on the aqueous solubility of sparfloxacin 
Solubility (mg/ml) ∆ G (J/mol) (25 º C) Cosolvent  
Conc., %v/v Ethanol Glycerol Propylene 
glycol 
Ethanol Glycerol Propylene glycol 
0.0 0.220 0.220 0.220 - - - 
10 0.287 0.239 0.262 -659.0 -203.3 -433.1 
15 0.341 0.267 0.292 -1083.0 -479.0 -700.8 
20 0.399 0.285 0.330 -1475.7 -644.7 -1005.9 
25 0.451 0.303 0.363 -1781.5 -801.8 -1238.3 
 
Table 2:  Effect of micellar solutions on the aqueous solubility of sparfloxacin 
Polysorbate-80 Sodium lauryl sulfate Surfactant 
Conc. (% w/v) Solubility 
(mg/ml) 
∆G (J/mol) 




(25 º C) 
0.00 0.220 - 0.220  
0.20 0.292 -697.3 0.702 -2877.0 
0.40 0.317 -1202.3 1.146 -4090.8 
1.0 0.390 -1406.8 2.815 -6316.9 






















Fig. 2: Plot of aqueous solubility (mg/ml) of 
sparfloxacin versus concentration of surfactant.  
The upper graph (□----□) is sodium lauryl 
sulfate; lower graph (▫----▫) is polysorbate-80  
 
The graph indicates an exponential increase in 
sparfloxacin solubility with increasing cosolvent 
concentration. For instance, at a concentration level 
of 25 % v/v, solubility of sparfloxacin was 451.4 
µg/ml (2-fold increase), 362.6 µg/ml (1.6-fold 
increase) and 303.9 µg/ml (1.4-fold increase) for 
ethanol, propylene glycol and glycerol respectively.  
The difference in solubilizing power of the 
cosolvents might be due to the disruption of 
hydrogen bonding interactions in water molecules 
as well as a decrease in the dielectric constant of 
the cosolvent system.  The dielectric constant was 
calculated using this equation, ε c   =  εwsfws + ε ssfss, 
where ε  and f are the dielectric constant and 
volume fraction respectively and the subscripts c, 
ws, ss  represent values for the cosolvent, weaker 
solvent and stronger solvent respectively.   
 
 
The relationship between the total sparfloxacin 
solubility (Stot) in cosolvent system and cosolvent 
concentration can be described by:  log Stot = log Sw 
+ δ C, where Sw is drug solubility in water, C is the 
concentration of the cosolvent and δ is the 
solubilizing power.  The free energy change (∆ G) 
for different system was calculated from the 
thermodynamic relationship (Feldman and Gibaldi 
1967), ∆ G = -2.303RT log Sc /Sw , where Sc / Sw = 
ratio of the molar solubility of sparfloxacin in 
cosolvent to that of water.  The negative values of 
the free energy change indicate the spontaneity of 
the process.  The results are presented in Table 1.  
In Fig. 2, the experimental total solubility is plotted 
against the surfactant concentration.  The graph 
shows a linear relationship between the drug 
aqueous solubility and the surfactant concentration 
for both surfactants.  It was also found from the 
graphs that sodium lauryl sulfate produced a more 
solubilizing effect than polysorbate-80. For 
example, considering a concentration level of 2 % 
w/v, the solubility of sparfloxacin was 4921.3 µg/ml 
(22.4-fold increase) for sodium lauryl sulfite 
compared to 817.4 µg/ml polysorbate-80 (3.7 fold 
increase).  In addition to its surfactant properties, 
the effect of sodium lauryl sulfate on sparfloxacin 
solubility could probably be a pH effect resulting in 
sufficient increase in the drug’s total aqueous 
solubility by ionized species of sparfloxacin in the 
micelle. The relationship between the total 
sparfloxacin solubility (Stot) in a micellar solution 
(Table 2) and surfactant concentration is given by : 
Stot = Sw + kSw C, where Sw is the drug solubility in 
water, C is the concentration of surfactant (i.e. total 
surfactant concentration minus the critical micelle 
concentration) and k is the micellar partition 
coefficient.  When the critical micelle concentration 
(cmc) is small, C can be approximated to the total 
surfactant concentration.  The free energy change 
for the different systems was calculated as 
previously described.  Once again, the negative 






















Study on the solubilization of sparfloxacin by aqueous cosolvent and micellar solutions 
 
604
Conclusion: The study shows that the aqueous 
solubility of sparfloxacin has been slightly enhanced 
by the cosolvent systems investigated.  It was also 
found that the surfactants were better solubilizing 
agents than the cosolvents.  Sodium lauryl sulfate 
produced very significant enhancement of 
sparfloxacin aqueous solubility than polysorbate-80.  
Finally, the study suggests that (i) cosolvency is not 
a good method for modifying aqueous solubility of 
sparfloxacin, (ii) although micellar solution of 
sodium lauryl sulfate at 2 % w/v produced very 
significant increase in aqueous solubility of 
sparfloxacin, its enhancement is not sufficient 
enough to solubilize the minimum therapeutic 
dosage strength of the drug necessary for it to be 
formulated into any liquid dosage form, (iii) toxicity 
effect might limit the use of higher concentrations of 
sodium lauryl sulfate in an attempt to obtain the 
aqueous solubility that could solubilize the minimum 
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